Journal of Magnetic Resonance Imaging

Background: Despite advances in organ-preserving strategies for rectal cancer, accurate restaging after neoadjuvant therapy (NAT) remains challenging due to the limited sensitivity of conventional MRI in differentiating residual tumour from treatment-induced changes. This limitation highlights the urgent need to develop better imaging tools that can accurately analyze the complex structure of the treated rectal wall. Purpose: To study the diffusion properties of different rectal wall components, including healthy layers and pathological tissue, using high-resolution ex vivo diffusion MRI (dMRI) on whole total mesorectal excision (TME) samples obtained after NAT, and to evaluate how advanced diffusion metrics improve tissue analysis compared to standard T2-weighted imaging. Materials and Methods: Five post-NAT TME specimens were prospectively collected at a single center and fixed (36h formalin, 4h PBS). Then, specimens were mounted in Fomblin and scanned using a 9.4T Bruker BioSpec (22{degrees} ; 86 mm Tx/Rx). Diffusion MRI was acquired using a 2D multi-shell sequence (TR/TE 11,000/24 ms; 130 slices; 0.5 mm3 isotropic voxel; b = 1500 and 3000 s/mm; 15 directions) alongside multi-echo T2;-weighted imaging (TR 25,000 ms; 8 echoes; TE 10-80 ms; fat suppression). Diffusion and kurtosis parametric maps were generated by voxelwise linear least-squares fitting; T2 maps by monoexponential fitting (MATLAB). Specimens were sectioned at 5 mm, stained with H&E and dual staining (for fibrosis and smooth muscle), digitized, and co-registered with MRI using morphological landmarks. Regions-of-interest (ROIs) - mucosa, submucosa, muscle layers, tumour, and fibrous tissue - were compared using a linear mixed-effects model with FDR correction (RStudio v2025.09). Results: The muscularis propria exhibited the highest FA values of all tissue components, reflecting the ordered fiber architecture of its inner circular and outer longitudinal layers, which were visually separable on direction-encoded colour FA maps. Focal disruption of anisotropy at the tumour-muscle interface corresponded histologically to tumour invasion of the muscularis propria. Tumour regions showed the lowest mean diffusivity (MD), reflecting high cellularity and restricted diffusion, and MD was comparatively higher in the residual scar. Kurtosis metrics - particularly MK and AK - were elevated in tumour, reflecting greater microstructural heterogeneity and complexity. T2 mapping provided limited contrast across tissue types due to formalin fixation effects. Conclusion: Diffusion MRI metrics quantitatively discriminated rectal wall tissue components ex vivo with histological validation, beyond T2-weighted contrast. DTI and DKI metrics characterized tumour, fibrous tissue, and muscularis propria invasion, supporting their potential as microstructural imaging biomarkers for treatment response assessment.

Despite the increased water content in fibrotic livers, numerous studies reported a decrease in ADC (apparent diffusion coefficient) in liver fibrosis. We argue that the ADC decrease in fibrotic livers is due to the T2 shine-through of ADC, as the longer T2 in liver fibrosis leads to less signal decay between the low and high b-value images. The metric slow diffusion coefficient (SDC) was proposed to mitigate the difficulties associated with this T2 shine-through of ADC. This study calculated ADC and SDC of one rat study with liver fibrosis induced by biliary duct ligation (BDL), and three sets of human liver fibrosis data. To tease out the menopausal effect on SDC, only the results of mens livers were analysed for the human datasets. The rat study showed, liver ADC decreased stepwise (in weeks after BDL procedure) following fibrosis induction, SDC increased stepwise. In human studies, all three datasets consistently showed advanced fibrosis had an ADC lower than that of earlier stage fibrosis; advanced fibrosis had a SDC higher than that of earlier stage fibrosis. When each liver SDC datum was normalized by the mean value of the controls without fibrosis, and the three human datasets were summed together, stage-1 liver fibrosis had a normalized SDC value lower than that of the controls, and there was a stepwise increase of SDC value from stage-1 liver fibrosis to stage-4 liver fibrosis. It is known that liver fibrosis is associated with lower perfusion, higher iron/susceptibility, and higher water content, and these three factors all contribute to the lower ADC measure. Higher iron/susceptibility lowers SDC measure, whereas higher water content elevates SDC measure. It is likely that for early-stage fibrosis, the net effect of susceptibility and water leads to a lower SDC, while for advanced fibrosis, the net effect leads to a higher SDC.

Background: Brain magnetic resonance elastography (MRE) is an emerging quantitative neuroimaging technique that provides noninvasive maps of brain tissue viscoelasticity. For multi-center applications, robust cross-site reproducibility across scanner platforms is essential but remains insufficiently characterized. Purpose: To evaluate cross-site reproducibility of brain multifrequency MRE measurements between two MRI scanner platforms using harmonized protocols. Study Type: Prospective cross-site test-retest reproducibility study. Study Population: Sixteen healthy adult volunteers (7 men, 9 women; mean age 32.2 +/- 8.0 years). Field Strength/Sequence: 3 T systems (Siemens MAGNETOM Cima.X and MAGNETOM Vida at two sites) with identical brain multifrequency MRE sequences, echo-planar imaging (EPI) readout, and standardized driver configuration. Assessment: Each participant underwent one MRE acquisition at each site. Shear wave speed (SWS) and penetration rate (PR) were quantified in whole brain, white matter, subcortical gray matter, and cortical gray matter regions using atlas-based region-of-interest (ROI) analysis in MNI152 space. Statistical Tests: Absolute relative difference (ARD), reproducibility coefficient (RDC), coefficient of variation (CV), intraclass correlation coefficient (ICC), and Bland-Altman plots were calculated to determine cross-site reproducibility. Results: Cross-site reproducibility was robust for major brain regions, with region-averaged ARD values for SWS ranging from 1.38 % to 3.43 % and for PR from 3.20 % to 7.25 % across tissues. RDCs for SWS ranged from 0.02 m.s^-1 to 0.07 m.s^-1 , and for PR from 0.03 m.s^-1 to 0.08 m.s^-1. Coefficients of variation for SWS ranged from 0.82 % to 1.93 %, and for PR from 2.21 % to 4.09 %. ICC values for SWS ranged from 0.66 to 0.84 and for PR from 0.67 to 0.88. Bland-Altman analysis showed minimal systematic bias and tight limits of agreement. Conclusion: Brain multifrequency MRE demonstrates robust reproducibility across distinct 3 T platforms when using harmonized acquisition and reconstruction. These results support the use of brain MRE as a quantitative biomarker and provide benchmark reproducibility metrics for future research.

BACKGROUNDMild traumatic brain injury (mTBI) is a signature injury in civilian and military populations that remains invisible to detection by conventional radiological methods. Diffusion MRI has been identified as a potential clinical tool for revealing subtle microstructural alterations associated with mTBI. OBJECTIVEThis study evaluates whether a comprehensive and powerful diffusion MRI (dMRI) technique called mean apparent propagator (MAP) MRI can detect sequelae of mTBI. METHODSWe analyzed data from 417 participants of the GE/NFL prospective mTBI study which included 143 matched controls (mean age, 21.9 {+/-} 8.3 years; 76 women) and 274 patients with acute mTBI and GCS [≥]13 (mean age, 21.9 {+/-} 8.5 years; 131 women). All participants underwent MRI exams at up to four visits including structural high-resolution T1W, T2W, FLAIR-T2W, and dMRI, in addition to clinical assessments of post-concussive physical symptoms (RPQ-3), psychosocial functioning and lifestyle symptoms (RPQ-13), and postural stability (BESS). The dMRI data for each subject were co-registered across all visits and analyzed using the MAP-MRI framework to measure and map the distribution of net microscopic displacements of diffusing water molecules in tissue and ultimately compute the microstructural MAP-MRI tissue parameters including propagator anisotropy (PA), Non-Gaussianity (NG), return-to-origin probability (RTOP), return-to-axis probability (RTAP), and return-to-plane probability (RTPP). We quantified voxel-wise and region-of-interest (ROI)-based changes in these parameters across all four visits. RESULTSMAP-MRI parameter values were within the expected ranges and showed relatively little variation across visits. We found no significant differences in the longitudinal trajectories of these parameters between mTBI patients and controls. At acute post-injury timepoints, RPQ-3 and RPQ-13 scores were increased in mTBI patients relative to controls, while BESS scores were not significantly different between groups. Analysis of dMRI metrics and clinical mTBI markers showed significant correspondence between MAP-MRI metrics in cortical gray matter, caudate and pallidum and BESS scores. CONCLUSIONWe developed and tested a state-of-the-art quantitative image processing pipeline for sensitive analysis and detection of subtle tissue changes in longitudinal clinical diffusion MRI data. The absence of a significant statistical difference between populations in the dMRI parameters in this study suggests that the mTBI corresponded to acute post-injury clinical symptoms but that the injury was not severe enough to cause detectable microstructural damage/alterations, and that increased diffusion sensitization combined with improved analysis techniques may be needed. CLINICAL IMPACTThese findings suggest that acute mTBI (GCS[≥]13) may not be detectable with diffusion MRI. TRIAL REGISTRATIONClinicalTrials.gov NCT02556177

Background: Recently, a posterior pathway for fluid drainage from the retina to the meningeal lymphatics in the optic nerve (ON) sheath was identified in rodents using intravitreal imaging tracers directly injected into the ocular-globe. Fluid and solute clearance along this pathway may be associated with many diseases. However, intravitreal tracers are rarely used in clinical imaging. As intravenous Gadolinium-based-contrast-agent (GBCA) can enter the globe via the blood-ocular-barriers, it may provide an alternative approach to image this pathway. Purpose: To establish a clinically feasible intravenous GBCA-based MRI approach for tracking fluid and solute transport along the posterior lymphatic pathway in the ocular glymphatic system. Materials & Methods: This prospective study was conducted from March 2021 to September 2022 in healthy participants. Dynamic-susceptibility-contrast-in-the-CSF (cDSC) MRI was performed before, immediately and 4 hours after intravenous-GBCA administration to track GBCA distribution in aqueous humor (AH) and cerebrospinal fluid (CSF) in regions-of-interest (ROIs) in the globe (anterior-cavity, vitreous-body), in the intraorbital and extraorbital ON, and in the intracranial CSF space proximal to the ON (chiasmatic-cistern, interpeduncular-cistern). Kruskal-Wallis tests with post-hoc Dunn's tests were used for group comparisons. Results: Sixteen healthy participants (mean age +/- SD: 51 +/- 21 years, 5 men) were recruited. Intravenous-GBCA enhancement was observed in all ROIs immediately after injection. At 4-hour-post-GBCA, the vitreous body showed a trend of smaller enhancement area (55 +/- 11% versus 49 +/- 11%, P=.14) and lower GBCA-concentration (0.044 +/- 0.014 versus 0.028 +/- 0.010 mmol/L, P=.07) compared to immediate-post-GBCA. The intraorbital ON showed more widespread enhancement (39 +/- 5% versus 59 +/- 6%, P=.01) and significantly higher GBCA-concentration (0.023 +/- 0.009 versus 0.059 +/- 0.015 mmol/L, P<.001) at 4-hour-post-GBCA. Conclusion: Dynamic fluid and solute transportation along the posterior lymphatic pathway in the ocular glymphatic system in healthy participants was measured by tracking intravenous-GBCAs entering the globe via the blood-ocular-barriers using cDSC-MRI.

Objective: To demonstrate the proof of principle that machine learning (ML) can be used to quantify Gleason Pattern (GP) 4 on digitized biopsy slides using multiple measurement approaches, allowing direct comparison of their prognostic performance. Methods: We assembled a convenience sample of 726 patients with grade group 2-4 prostate cancer on systematic biopsy who underwent radical prostatectomy between 2014 and 2023. Digitized biopsy slides were analyzed using a machine-learning algorithm (PAIGE-AI) to quantify GP4 using multiple measurement approaches, particularly with respect to how gaps between cancer foci (interfocal stroma) were handled. GP4 extent was quantified using linear measurements or a pixel-based area metric. Discrimination of each GP4 quantification approach, along with Grade Group (GG), was assessed for adverse radical prostatectomy pathology and biochemical recurrence. Results: We identified 15 different quantification approaches and observed differences between their discrimination. The highest discrimination was in the pixel-counting method (AUC 0.648). GP4 quantification outperformed GG for predicting adverse pathology (AUC 0.627 vs 0.608). Amount of GP3 was non-predictive once GP4 was known. These findings were consistent for BCR. Conclusions: We were able to measure slides using 15 distinct measurement approaches and replicated prior findings using ML to quantify GP4. Our findings support the use of ML as a research tool to compare different GP4 quantification approaches. We intend to use our method on larger cohorts to determine with which measurement approach best predicts oncologic outcome.

Objective. Quantitative T2 mapping plays a critical role in brain imaging for assessing a range of neurological conditions, including neurodegenerative diseases, demyelinating disorders, and cerebrovascular pathologies. Despite its diagnostic potential, implementing quantitative T2 mapping at ultra-high magnetic field strengths ([&ge;]7T) poses significant challenges. These include elevated specific absorption rate (SAR) and radiofrequency (RF) field inhomogeneities, which can lead to prolonged scan durations and inaccuracies in quantification. Materials and Methods. Phase-based gradient-recalled echo (GRE) techniques have recently emerged as promising rapid acquisition with enhanced sensitivity to T2-related contrast. In this study, we introduce TWISTARE (TWo Interleaved Steady-states for T2 and RF Estimation), a novel dual steady-state 3D-GRE approach that employs interleaved flip angles and small RF phase increments to jointly estimate T2 and B1 maps. By combining two dual-steady-state scans, TWISTARE enables fast, whole-brain quantitative T2 mapping while reducing scan time and mitigating B1-related bias at ultra-high field. Results. Validation experiments included Bloch simulations, phantom studies and in-vivo imaging. The results demonstrated high precision in phantom experiments, achieving up to a two-fold reduction in acquisition time and achieved precision comparable to the gold-standard method in vivo within a similar scan duration. Discussion. TWISTARE establishes a fast steady-state framework for quantitative neuroimaging at ultrahigh field, offering potential benefits for both clinical and research applications, especially in longitudinal and dynamic studies of brain tissue.

Focal cortical dysplasias (FCDs) are one of the most common structural causes of drug-resistant epilepsy in children but are frequently subtle and difficult to detect on conventional MRI. Many automated lesion detection methods have therefore been proposed to support neuroradiological assessment. In this study, we externally validated two recently developed deep-learning approaches for FCD detection, MELD Graph and 3D-nnUNet, in a pediatric cohort. In this retrospective single-center study, brain MRI scans of 71 children evaluated for epilepsy were analyzed, including 35 MRI-positive patients with suspected FCD and 36 MRI-negative cases based on the primary radiology reports. Both models were applied to standard 3D T1-weighted and 3D FLAIR images. Detected lesions were reviewed by an experienced pediatric neuroradiologist and classified as true positive, false positive, or false negative. Clinical semiology and EEG findings were additionally evaluated for cases with false-positive detections. At the lesion level, MELD Graph achieved a precision of 0.85 and recall of 0.52, while 3D-nnUNet achieved a precision of 0.91 and recall of 0.48. In the MRI-negative patients, MELD Graph produced more false-positive detections than 3D-nnUNet (0.53 vs. 0.14 false-positive lesions per patient). At the patient level, MELD Graph showed slightly higher sensitivity than 3D-nnUNet (0.63 vs. 0.54), whereas 3D-nnUNet demonstrated markedly higher specificity (0.86 vs. 0.56). Improved FLAIR image quality was associated with trends toward improved model performance. Both models demonstrated high precision but moderate sensitivity, indicating that they are valuable decision-support tools but cannot replace expert neuroradiological evaluation. Optimized MRI acquisition protocols are needed to further improve automated lesion detection in pediatric epilepsy.

PURPOSEGlycolytic production of HDO from the metabolism of perdeuterated glucose provides a means for metabolic imaging with 2H MRI. The present study compared HDO production from a cost-efficient [2,3,4,6,6-2H5]glucose with [2H7]glucose in vitro and in vivo. METHODS2H NMR spectroscopy was performed to measure glucose consumption, lactate, and HDO production in the SFxL glioblastoma cell line. In vivo studies in healthy mice using 2H magnetic resonance spectroscopy were performed at 11.1 T after administering a bolus of either metabolic contrast agent. In vivo metabolite levels were quantified using unlocalized and slice-selective localized spectra. RESULTSOur in vitro results demonstrated similar glucose consumption and HDO production kinetics, although significant differences in lactate labeling were observed. The in vivo study showed comparable glucose consumption and HDO production kinetics following tail-vein bolus administration of either metabolic contrast agent, while lactate was not detected in the brain. CONCLUSION[2,3,4,6,6-2H5]glucose shows comparable HDO production to [2H7]glucose, while offering lower cost and reduced spectral complexity. These findings place [2,3,4,6,6-2H5]glucose as an alternative to [2H7]glucose for HDO-based DMI studies.

Purpose: To develop a deep neural network-based, AIF-free, perfusion estimation method (QTMnet) for improved performance on glioma classification. Methods: A globally defined arterial input function (AIF) is needed to recover perfusion parameters in the two-compartment exchange model (2CXM). We have developed Quantitative Transport Mapping (QTM) to create an AIF-independent estimation method. QTM estimation can be formulated using deep neural networks trained on synthetic DCE-MRI data (QTMnet). Here, we provide a fluid mechanics-based DCE-MRI simulation with exchange between the capillaries and extravascular extracellular space. We implemented tumor ROI generation to morphologically characterize tissue perfusion. We compared our QTMnet implementation with 2CXM on 30 glioma human subjects, 15 of which had low-grade gliomas, and 15 with high-grade glioblastomas. Results: QTMnet outperforms (best AUC: 0.973) traditional 2CXM (best AUC: 0.911) in a glioma grading task. Conclusion: The AIF-independent QTMnet estimation provides a quantitative delineation between low-grade and high-grade gliomas.

BackgroundQuantitative cerebral blood flow (CBF) measured with [15O]water positron emission tomography (PET) is the reference standard for quantifying brain perfusion. However, clinical interpretation of individual CBF measurements is limited by the absence of large normative datasets accounting for physiological variability across the adult lifespan. Long-axial field-of-view PET enables high-sensitivity quantitative [15O]water perfusion imaging without arterial blood sampling, allowing normative characterization of cerebral perfusion at unprecedented scale. The aim of this study was to establish normative and covariate-adjusted models of cerebral blood flow across the adult lifespan using total-body [15O]water PET. MethodsQuantitative CBF measurements were obtained in 302 neurologically healthy adults (age 21-86 years) using total-body [15O]water PET. Linear mixed-effects models were used to evaluate the effects of age, sex, body mass index (BMI), and blood hemoglobin concentration on CBF and to generate normative prediction models across the adult lifespan. Between-subject and within-subject variability were estimated from repeated scans in a subset of participants (n=51). ResultsMean grey matter CBF was 46.1 mL/(min*dL), with substantial inter-individual variability but high within-subject reproducibility (intraclass correlation coefficients 0.78-0.89). Advancing age was associated with a decline in CBF of approximately 7% per decade (p_FDR < 10-12). Higher BMI was associated with lower CBF (approximately -6% per 10 kg/m2; p_FDR < 0.01). Women exhibited higher CBF than men (approximately 7.5%), but this difference was largely explained by lower blood hemoglobin concentration in women. Covariate-adjusted models were used to generate normative predictions and prediction intervals describing expected CBF across adulthood. ConclusionThis study establishes a normative database of quantitative cerebral blood flow across the adult lifespan using high-sensitivity [15O]water PET. Age, BMI, and hemoglobin are major determinants of inter-individual variability in CBF. The resulting generative models provide a quantitative reference framework for interpreting cerebral perfusion measurements and may enable automated detection of abnormal brain perfusion in clinical PET imaging.

PurposeTo create a realistic in-silico brain phantom for positive and negative magnetic susceptibility that incorporates susceptibility anisotropy, enabling the evaluation of how susceptibility anisotropy influences susceptibility separation algorithm performance. MethodsWe expanded an existing QSM validation phantom by creating separate maps for positive and negative susceptibility, with the option of modeling susceptibility anisotropy. Multi-echo gradient echo data were simulated to evaluate four susceptibility separation techniques ({chi}-separation, DECOMPOSE-QSM, APART-QSM, and [Formula]). To assess the impact of noise, simulations were performed at different SNR levels (50, 100, 200, 300). ResultsOur findings showed that the error in negative susceptibility estimates increased by up to 53% when susceptibility anisotropy was present, compared to the case without susceptibility anisotropy, with {chi}-separation being the algorithm that was most sensitive to anisotropy. Robustness to noise varied across the assessed algorithms, with APART-QSM and {chi}-separation having the highest and lowest sensitivity to noise, respectively. ConclusionThe modified phantom is open-source and can serve as a numerical ground truth for evaluating susceptibility separation methods. Our findings emphasize the importance of incorporating susceptibility anisotropy into susceptibility separation models to improve their accuracy.

A substantial body of evidence demonstrates that measures from mammograms are predictive of breast cancer risk. In this matched case-control study, mammograms acquired near the time of diagnosis were analyzed to investigate bilateral breast asymmetry as measure of short-term risk prediction. Specifically, contralateral breast images were compared with measures derived in the Fourier domain (FD); this technique summarizes power in concentric radial bands that cover the Fourier plane. Equivalently, this approach can be described as a multiscale characterization of the image. The summarized power difference between respective contralateral bands produces an asymmetry measure. Full field digital mammography (FFDM) and synthetic two-dimensional images from digital breast tomosynthesis (DBT) were investigated for women that had both types of mammograms acquired at the same time. Odds ratios (ORs) and the area under the receiver operating curves (Azs) were generated from conditional logistic regression modeling with 95% confidence intervals. Raw unprocessed FFDM images produced significant findings: OR = 1.90 (1.58, 2.29) and Az = 1.72 (0.67, 0.76) per one standard deviation unit. Associations were significant but attenuated for both clinical FFDM and DBT images: OR = 1.31 (1.11, 1.54) and Az = 0.63 (0.58, 0.67); and OR = 1.48 (1.25, 1.76) and Az = 0.65 (0.60, 0.70), respectively. Results suggest that clinical FFDM and DBT images are inferior to raw FFDM images in capturing breast asymmetry with information loss for breast cancer risk prediction. Moreover, these DBT images have lower spatial resolution but produced stronger associations than the clinical FFDM images.

Understanding the time course of Alzheimer's disease biomarkers of amyloid and tau pathology and their temporal relation to clinical symptoms is key to identifying optimal windows for disease intervention and planning future drug trials. The goal of this work was to determine the extent to which Sampled Iterative Local Approximation (SILA), an algorithm extensively validated for amyloid PET, is capable of modeling longitudinal tau (T) PET trajectories and estimating person-level tau positivity onset ages in two commonly analyzed brain regions and two tracers from two different cohorts. Methods: 385 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI; mean (SD) age = 73.4 (7.3) years) with longitudinal flortaucipir tau PET and 288 participants from the Wisconsin Registry for Alzheimer's Prevention and Wisconsin Alzheimer's Disease Research Center (collectively referred to as WISC; mean (SD) age = 67.4 (6.7) years) with longitudinal MK-6240 tau PET were included in the study. Standard uptake value ratios (SUVRs) in the entorhinal cortex and a meta-temporal ROI were modeled with SILA separately, for each cohort and region. Forward and backward SUVR and T+/- prediction were characterized with ten-fold cross-validation and in-sample validation techniques. Accuracy of estimated T+ onset ages (ETOA) was characterized in T- to T+ converters. Differences in ETOA were tested between APOE-e4 carriers and non-carriers, as well as differences in time T+ between levels of cognitive impairment. Results: SILA was able to accurately estimate retrospective change in tau SUVR in the meta-temporal region regardless of age, sex, APOE-e4 carriage, tau SUVR, and dementia (p >0.05) whereas dementia was associated with model residuals in entorhinal cortex (p [&le;] 0.05; ADNI). In subsets of observed T- to T+ converters, the difference between "observed" and estimated meta-temporal T+ onset age [95% CI] was 0.12 [-0.27, 0.52] years for ADNI and -0.09 [0.93, 0.74] years for WISC. ETOA was significantly earlier, and odds of SILA-estimated T+ status were higher amongst APOE-e4 carriers (p <0.05) and those with dementia (p <0.05). Conclusions: Our results suggest SILA can be used to accurately model longitudinal tau PET trajectories and retrospectively estimate individual T+ onset ages in the meta-temporal region. The accuracy of SILA time estimates in entorhinal cortex worsened amongst those with dementia in ADNI suggesting entorhinal cortex may only be suitable for studying the temporal progression of tau during the preclinical time frame.

The hippocampal CA1 subregion supports learning, memory formation, and spatial navigation. Although its three-layered architecture has been described in ex-vivo investigations, the in-vivo microstructural profile of CA1 and its relation to individual variations in memory performance remain poorly characterized. In this study, we used ultra-high field structural MRI at 7 Tesla to investigate the depth-dependent myelination patterns (measured by quantitative T1) of CA1 in younger adults, their relation to the local arterial architecture, and their association with individual differences in cognitive functions, specifically memory performance. Results show that left and right CA1 present depth-dependent patterns of myelination, with the outer and inner compartments showing higher myelination than the middle compartment. No significant relationship between layer-specific myelination of CA1 and distance to the nearest artery was observed. Right CA1 was found to be more myelinated than left CA1. Pairwise correlations and regression models showed that higher left CA1 myelination is linked to higher accuracy in object localization. Together, our data demonstrates the feasibility of describing the three layered myelin architecture of CA1 in vivo, and provides information on how alterations in the architecture of CA1 may relate to alterations in cognitive performance in younger adults.

Resting-state functional MRI has been widely used to study brain connectivity, yet the test-retest reliability of commonly used metrics remains a concern. To improve reliability, extended scan lengths and larger subject cohorts are often recommended. However, these solutions can be impractical and pose challenges, particularly in studies of clinical populations. Here, we systematically assess the reliability of two main types of functional connectivity measures: node-based connectome metrics (edge-level intraclass correlation coefficient [ICC], connectome-level ICC, functional connectivity fingerprinting, and discriminability); and voxel-based resting-state networks (RSNs) (spatial similarity of independent component analysis [ICA]-derived RSN maps quantified using the Dice coefficient). Using data from the Human Connectome Project, we evaluated the effects of scan length (3.6, 7.2, 10.8, and 14.4 minutes) and number of participants (n = 10, 20, 50, and 100), on both within-session and between-session reliability. We found that multivariate connectome metrics demonstrated greater reliability than edge-level measures, and that scan length had stronger influence on test-retest reliability than the number of participants. For connectome metrics, 14 minutes of scanning and a cohort of approximately 20 participants were sufficient to achieve reliable estimates. In contrast, RSN measures benefited from larger cohort sizes. Our findings provide practical guidelines for designing resting-state fMRI studies in terms of scan length and number of participants, balancing reliability and feasibility. Ultimately, protocol choices should be guided by the specific study objectives and the functional connectivity metric of interest.

Null Subtraction Imaging (NSI) is a nonlinear beamforming approach that combines multiple receive apodizations and subtraction to improve spatial resolution in ultrasound imaging. In NSI, a DC offset parameter is introduced in the apodization design to control the sharpening of the effective beam pattern and, therefore, the degree of spatial-resolution enhancement. Here, we investigate the use of NSI in functional ultrasound (fUS) imaging of the mouse brain and compare its performance with conventional delay-and-sum (DAS) beamforming across a range of DC offset values. fUS acquisitions were performed in three anesthetized wild-type mice during periodic vibrissae stimulation. Activation maps were computed by correlating cerebral blood volume (CBV) signals with the stimulation pattern. Activation area, edge gradient, Dice similarity coefficient, and signal-to-noise ratio (SNR) were used to evaluate spatial localization, boundary sharpness, vascular alignment and signal stability, respectively. NSI yielded more spatially confined activation maps than DAS and produced sharper activation boundaries. However, for low DC offsets (DC < 0.5), the CBV signal exhibited increased fluctuations, which reduced temporal stability and limited the reliability of the functional maps. As the DC offset increased, temporal SNR improved, while the spatial-resolution gain progressively decreased. In our imaging configuration, intermediate DC values around DC {approx} 0.5 provided the most favorable compromise between improved spatial localization and sufficient temporal stability for reliable functional activation detection. These results demonstrate the feasibility of applying NSI to functional ultrasound imaging and provide a quantitative framework for selecting the DC parameter in fUS studies.

The photon measurement density function (PMDF) plays a fundamental role in both pre-experimental optode arrangement and post-experimental data analysis in functional near-infrared spectroscopy (fNIRS). Conventionally, PMDFs are derived from structural MR images through tissue segmentation and photon propagation modeling (PPM), which are computationally demanding and time-consuming, thereby limiting their practical use. In this study, we propose a novel deep learning-based framework to estimate PMDFs directly from MR images and channel configurations. The proposed method supports flexible source-detector distances and eliminates the need for explicit tissue segmentation and repeated photon simulations. Specifically, a convolutional neural network is trained to predict photon fluence distributions, from which PMDFs are subsequently derived using the adjoint formulation. The trained model is evaluated on channels placed in both trained and unseen scalp regions across commonly used source-detector distances. The results demonstrate that the proposed method achieves PMDF estimations comparable to those obtained from PPM. Overall, this approach significantly reduces computational cost and has the potential to facilitate broader adoption of PMDF-based methods in the fNIRS community.

Background. Breast cancer (BC) remains the most diagnosed malignancy and leading cancer-related cause of mortality in women worldwide. Although blood-based untargeted metabolomics has emerged as a promising modality for detecting early-stage BC, the clinical translation of this approach has been bottlenecked by two unresolved issues: (i) the field has almost exclusively relied on serum or plasma, which require venipuncture and cold-chain logistics, and (ii) machine-learning models reported on such data are frequently validated with protocols that are blind to analytical batch structure, producing optimistically biased performance estimates. Methods. We present a breast cancer detection study based on dried blood spots (DBS), an analytical matrix that enables self-collection and ambient-temperature shipping. A cohort of 2,734 participants (114 biopsy-confirmed BC cases; 2,620 non-cancer controls) was profiled by untargeted LC-MS/MS on a Thermo Scientific Orbitrap IQ-X coupled to a Vanquish UHPLC. A 39-metabolite panel meeting MSI Level 1 identification criteria was pre-specified a priori from the published breast-cancer metabolomics literature, frozen prior to LC-MS acquisition, and applied to the present cohort without any feature selection on the data. Six standard supervised-learning architectures (LASSO, Elastic Net, Linear SVM, PLS-DA, OPLS-DA, XGBoost) were evaluated on this pre-specified panel; OPLS-DA is reported only in the sex-matched subgroup analysis where a single-seed 5-fold stratified protocol permits a directly comparable fit. Per-batch control-median normalization is applied upstream; kNN imputation, log transform, and robust scaling are fit within each training fold. The evaluation battery comprises batch-aware StratifiedGroupKFold CV at single-seed (seed=42) with inter-seed SD quantified across 10 independent seeds, batch-aware nested CV, a 100-seed held-out 20%-batch validation with disjoint-batch isotonic probability calibration (30% calibration partition), PPV/NPV reporting at multiple operating points and three deployment prevalences, subgroup analyses by TNM stage and tumor grade, pathway-ablation sensitivity analysis, and a 1,000-iteration permutation test. Results. Under batch-aware evaluation (StratifiedGroupKFold, single-seed=42), AUC ranged from 0.914 to 0.949 across classifiers, with LASSO achieving 0.928 and XGBoost 0.949; inter-seed SD across 10 seeds was 0.002-0.006. At 95% specificity, LASSO reached 75.4% sensitivity and XGBoost 81.6%. Held-out batch validation (100 seeds) yielded mean AUC 0.912 for Elastic Net and 0.935 for XGBoost, confirming robust generalization. All 39 panel features showed high coefficient stability, and permutation testing on representative classifiers (LASSO, Linear SVM, PLS-DA) yielded p <= 0.001. Subgroup analyses showed weaker detection of stage IIA tumors (AUC 0.87, n=40) compared with stage IIB/IIIA (AUC 0.95), consistent with stronger metabolic signatures in more advanced disease. Bootstrap coefficient consistency of the Elastic Net classifier confirmed that all 39 panel features received a non-zero multivariate weight in >=80% of 100 stratified bootstraps. Conclusions. On this cohort of diagnosed, pre-treatment breast-cancer cases, DBS LC-MS metabolomic profiling delivers classification performance (AUC 0.928 for LASSO and 0.949 for XGBoost under batch-aware GroupKFold CV at single-seed=42; held-out AUC 0.912-0.935) that is robust across classifier families and biological pathways. The DBS matrix is non-radiating, self-collectable by finger-prick, and mailable at ambient temperature. Performance is weaker on stage IIA than on more advanced disease, and prospective validation in an independent asymptomatic screening cohort is required before clinical positioning as a decentralized triage modality.

Background: Medical imaging, especially computed tomography and magnetic resonance imaging, is essential in clinical care of patients with renal cell carcinoma (RCC). Artificial intelligence (AI) research into computer-aided diagnosis, staging and treatment planning needs curated and annotated datasets. Across literature, The Cancer Genome Atlas (TCGA) datasets are widely used for model training and validation. However, re-annotation is often necessary due to limited access to public annotations, raising entry barriers and hindering comparison with prior work. Methods: We screened 1915 CT scans from three TCGA-RCC databases and employed a segmentation model to annotate kidney lesion. After a meta-data-based exclusion step, we hosted a reader study with all papillary (n=56), chromophobe (n=27) and 200 randomly selected clear cell RCC cases. Two students quality checked and corrected the data as well as annotated tumors and cysts. Uncertain cases were checked by a board-certified radiologist. Results: After data exclusion and quality control a total of 142 annotated CT scans from 101 patients (26 female, 75 male, mean age 56 years) remained. This includes 95 CTs with clear cell RCC, 29 with papillary RCC and 18 with chromophobe RCC. Images and voxel-level annotations of kidneys and lesions are open sourced at https://zenodo.org/records/19630298. Conclusion: By making the annotations open-source, we encourage accessible and reproducible AI research for renal cell carcinoma. We invite other researchers who have previously annotated any of these cohorts to share their annotations.